Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)

NCT00080444 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Vomiting

Interventions

DRUG: aprepitant
DRUG: ondansetron
DRUG: dexamethasone
DRUG: placebo to aprepitant
DRUG: placebo to dexamethasone
DRUG: rescue medication

Sponsor

Merck Sharp & Dohme LLC